Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Ghofrani, Hossein-Ardeschir ; Simonneau, Gérald ; D'Armini, Andrea M ; Fedullo, Peter ; Howard, Luke S ; Jaïs, Xavier ; Jenkins, David P ; Jing, Zhi-Cheng ; Madani, Michael M ; Martin, Nicolas ; Mayer, Eckhard ; Papadakis, Kelly ; Richard, Dominik ; Kim, Nick H

The lancet respiratory medicine, 2017-10, Vol.5 (10), p.785-794 [Peer Reviewed Journal]

England

Full text available